ZEUS Scientific, Inc. - Product Pipeline Analysis, 2013 Update - New Market Research Report

From: Fast Market Research, Inc.
Published: Thu May 30 2013


ZEUS Scientific, Inc. ( ZEUS) is a pharmaceuticals company. The company develops and manufactures clinical diagnostic tests for the in-vitro diagnostic markets. Its products include ANA II plus test system, autoimmune vasculitis plus test system, dsDNA, EBV IgG plus test system, EBV IgM plus test system, EBV-early antigen (EA) IgG, EBV-nuclear antigen (NA) IgG, EBV-viral capsid antigen (VCA) IgG, EBV-viral capsid antigen (VCA) IgM, HSV-1 IgM, HSV-1&2 IgG plus test system, mycoplasma IgG, mycoplasma IgM, ZEUS IFA ANA HEp-2 test system 10 x 96 wells and ZEUS IFA ANA HEp-2 test system 25 x 12 wells. ZEUS is headquartered at Branchburg, New Jersey, the US.

This report is a source for data, analysis and actionable intelligence on the ZEUS Scientific, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Full Report Details at
- http://www.fastmr.com/prod/606102_zeus_scientific_inc_product_pipeline_analysis.aspx?afid=303

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
* Design and develop your product development, marketing and sales strategies.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2013 Update
- Thermo Fisher Scientific Inc. (TMO) - Product Pipeline Analysis, 2013 Update
- ZEUS Scientific, Inc. - Product Pipeline Analysis
- Siemens Healthcare - Product Pipeline Analysis, 2013 Update
- Varian Medical Systems, Inc. (VAR) - Product Pipeline Analysis, 2013 Update

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »